Primary Biliary Cholangitis or PBC

(formerly known as Primary Biliary Cirrhosis)

Itchiness is a lesser known aspect of PBC liver disease that can impact sleep, mood and activities of daily living for patients. A clinical trial is researching the ability of an investigational medicine to treat PBC related itchiness.

Check eligibility?

Study details

Study details

Drug
GSK2330672

Phase
2

Number of participants
140

Duration
This trial is up to 30 weeks long, requiring up to 7 visits, 1 telephone call, and no overnight stays.

Is a placebo being used?
Yes

Sponsored by:
GlaxoSmithKline

Will the results of this trial be published?
Yes

Will patients be able to continue taking the medication after the trial?
No

Costs
All study related medications and procedures will be provided at no cost.

If you would like to speak to someone regarding this trial, first check to see if you meet the basic criteria above. If you meet the criteria and are interested in learning more about determining your eligibility we can contact you by phone to discuss additional eligibility requirements, discuss your interest and answer questions you may have about the clinical trial.